An indication indicates a COVID-19 curbside test at Heckley Community Care COVID-19 at 2700 Baker Street, Muscat Gon Na Heights, Mich., Friday, November 13, 2020.
ON Newsroom
Updated 7:51 AM PT – Saturday, November 14, 2020
Antidepressant reports that coronavirus can help fight serious illness in patients. According to reports received Friday, a clinical trial in St. Louis, Missouri, showed that the drug fluvoxamine can help prevent patients from developing conditions that have not yet been hospitalized.
152 patients were examined by the Washington Washington School School of Medicine. Antidepressant recipients did not experience “clinical deterioration,” while six patients who did not receive the drug did so.
Dr. Alban Gaulier with the Virginia School of Medicine reported that this clinical trial showed significant results.
“This is very comforting, however, we need to repeat our study with a larger number of patients, which will be called a Phase 3 clinical trial,” he explained. “And I think it will start soon.”
UVA researcher Dr. Alban Gauliator and team reverse depression symptoms in rats using probiotics https://t.co/X6MzSP5UH8
– UVA Mon Face Dev (@YuvasomFakeDev) March 9, 2017
Dr. Goulitier compared the antidepressant iroprophene to coronavirus, something that the patient may take as early as possible to monitor his condition.
Related: President Trump: The COVID vaccine should be approved next week
.
